What Researchers Did
The researchers gave human prostate cancer cells to 30 mice with weak immune systems, then exposed half of them to 20 sessions of hyperbaric oxygen and the other half to normal air.
What They Found
In a randomized mouse study, hyperbaric oxygen did not change the growth of transplanted human prostate cancer tumors: on day 28 the tumors measured 120 mm3 in the hyperbaric oxygen group and 122 mm3 in the control group. Microvessel density was 39.3 in the hyperbaric oxygen group and 36.2 in the control group. Ki-67 was 78.1 percent versus 75.3 percent, p53 was 40.4 percent versus 44.2 percent, and p27 was 63.7 percent versus 61.5 percent. The abstract reports no significant differences in any of these measures (p greater than 0.05).
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study used only 30 mice and one prostate cancer cell line, it followed tumors for just 4 weeks, and it reported no data from human patients, so it cannot show how hyperbaric oxygen affects prostate cancer in people.